Investigating the mechanisms underlying resistance to chemoterapy and to CRISPR-Cas9 in cancer cell lines (original) (raw)

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

Carolina Gutierrez

Journal of The National Cancer Institute, 2008

View PDFchevron_right

Recent developments in cancer research: Expectations for a new remedy

Masaki Mori

Annals of Gastroenterological Surgery

View PDFchevron_right

Chemotherapy resistance of glioblastoma stem cells

Francesco Lotti

Cell Death & Differentiation, 2006

View PDFchevron_right

CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens

Abdul Sami Sajid

Annals of Clinical Microbiology and Antimicrobials, 2019

View PDFchevron_right

Ability to Acquire Drug Resistance Arises Early during the Tumorigenesis Process

Parmjit Jat

Cancer Research, 2007

View PDFchevron_right

Cas clinique n° 6 Cancer métastatique

H. Lena

Revue des Maladies Respiratoires Actualités, 2015

View PDFchevron_right

Initiation of High Frequency Multi-Drug Resistance Following Kinase Targeting by siRNAs

barbara nicke

Cell Cycle, 2007

View PDFchevron_right

Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine

Sara Bashraheel

Biomedicine & Pharmacotherapy, 2020

View PDFchevron_right

CRISPR/Cas9: An Advance Tool in Genome Editing

Yogesh Wagh

2019

View PDFchevron_right

Preclinical Models of Tumor Growth and Response

Bill Elliott

Cancer Drug Discovery and Development

View PDFchevron_right

Integrated computational and experimental identification of p53, KRAS and VHL mutant selection associated with CRISPR-Cas9 editing

Karina Barbosa

2018

View PDFchevron_right

Cancer stem cells and addicted cancer cells

Johannes Boonstra

Oncology discovery, 2013

View PDFchevron_right

Editorial: Chemo-Resistance in Gastrointestinal Cancers

Prathibha Ranganathan

Frontiers in Oncology

View PDFchevron_right

CRISPR-Cas9 mutagenesis of the zebrafish foxm1

Ana Leonor Carvalho

2018

View PDFchevron_right

Cancer cell fitness is dynamic

Carolina Santo

Cancer Research, 2020

View PDFchevron_right

Data from Validation of a Radiosensitivity Molecular Signature in Breast Cancer

Jonas Bergh

2023

View PDFchevron_right

The role of deubiquitinating enzymes in cancer drug resistance

Suresh Ramakrishna

Cancer Chemotherapy and Pharmacology, 2020

View PDFchevron_right

CRISPR/Cas system: An emerging technology in stem cell research

Donato Zipeto

World Journal of Stem Cells, 2019

View PDFchevron_right

Re-targeting T-cells against cancer by gene-transfer of tumor-reactive receptors

Suzanne van Dorp

Expert Opinion on Biological Therapy, 2009

View PDFchevron_right

Application of Novel Molecular Biology in Cancer Therapy

asadollah asadi

Basic & Clinical Cancer Research, 2022

View PDFchevron_right

A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing

Karina Barbosa

Nature Communications, 2021

View PDFchevron_right

Targeting cancer stem cells in refractory cancer

Masaki Mori

Regenerative Therapy, 2021

View PDFchevron_right

Mutation Analysis of the C1 Inhibitor Gene

Arkadius Kocot

34th Hemophilia Symposium

View PDFchevron_right

Mouse xenograft models for elucidating resistance mechanisms to cancer therapeutics

Wenfa Ng

2015

View PDFchevron_right

CHEK2 Is a Multiorgan Cancer Susceptibility Gene

J. Gronwald

The American Journal of Human Genetics, 2004

View PDFchevron_right

Advanced technological tools to study multidrug resistance in cancer

Milica Pešić

Drug Resistance Updates, 2019

View PDFchevron_right

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

DURDI QUJEQ

Cellular & Molecular Biology Letters

View PDFchevron_right

106 Cancer Research in Africa

Clement Adebamowo

Journal of Acquired Immune Deficiency Syndromes, 2011

View PDFchevron_right

Recent Progress in Cancer Research

Abdenbi Khalqallah

Association of Schools of Public Health, 1953

View PDFchevron_right

Editorial Cancer Dormancy : A New Hope

Surajit Sinha

2018

View PDFchevron_right

Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations

Suresh Ramakrishna

Nature Communications, 2014

View PDFchevron_right

An overview on cell-based therapy: Unique perspective for cancer management

Rohit Bhosale

Asian Journal of Pharmacy and Pharmacology

View PDFchevron_right

NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells

M. Fillet

Oncogene, 2003

View PDFchevron_right

Validation of a Radiosensitivity Molecular Signature in Breast Cancer

Jonas Bergh

Clinical Cancer Research, 2012

View PDFchevron_right

Cancer Immunotherapy: A Systemic Review

Ashesh Chowdhury

Archives of oncology and cancer therapy, 2024

View PDFchevron_right